Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009 Oct 1;27(28):4656-63 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/19704057.
Compare quality appraisals for each clinical question
- NETs guidelines/Cytotoxic chemotherapy and other systemic treatments
- NETs guidelines/Radionuclide Therapy
- NETs guidelines/Short and Long-Acting Somatostatin Analogues (SSA)